# FDA Inspection 1252519 - Biopharmacotech Sp. z.o.o. Spolka Komandytowa - September 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/biopharmacotech-sp-zoo-spolka-komandytowa/3e65065b-3b9e-417e-8dc0-9b6583920618
Source feed: FDA_Inspections

> FDA Inspection 1252519 for Biopharmacotech Sp. z.o.o. Spolka Komandytowa on September 11, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252519
- Company Name: Biopharmacotech Sp. z.o.o. Spolka Komandytowa
- Inspection Date: 2024-09-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1252519 - 2024-09-11](https://www.keypedia.com/records/fda_inspections/biopharmacotech-sp-zoo-spolka-komandytowa/7e3a97db-8479-4d20-9e62-5145d7f960ad)
- [FDA Inspection 1027546 - 2017-09-15](https://www.keypedia.com/records/fda_inspections/biopharmacotech-sp-zoo-spolka-komandytowa/618dd6ec-48b3-486e-8ec2-337840561595)

Company: https://www.keypedia.com/companies/biopharmacotech-sp-zoo-spolka-komandytowa/e4af316c-db93-4e0f-a4b6-83bcc4ab30cf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c